| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antiaromatase Agents After Adjuvant Tamoxifen: Rationale and Clinical Implications
|
Mamounas, Eleftherios P.
|
|
2000
|
1 |
S1 |
p. S22-S27
6 p.
|
article
|
| 2 |
Antiaromatase Agents: Preclinical Data and Neoadjuvant Therapy
|
Miller, William R.
|
|
2000
|
1 |
S1 |
p. S9-S14
6 p.
|
article
|
| 3 |
Comparison of In Vitro Exemestane Activity Versus Other Antiaromatase Agents
|
Soudon, Jacques
|
|
2000
|
1 |
S1 |
p. S68-S73
6 p.
|
article
|
| 4 |
Epirubicin in Breast Cancer: Present and Future
|
Levine, Mark
|
|
2000
|
1 |
S1 |
p. S62-S67
6 p.
|
article
|
| 5 |
Exemestane Improves Survival in Metastatic Breast Cancer: Results of a Phase III Randomized Study
|
Kaufmann, Manfred
|
|
2000
|
1 |
S1 |
p. S15-S18
4 p.
|
article
|
| 6 |
Exemestane in Breast Cancer: Current Status and Future Directions
|
Lønning, Per E.
|
|
2000
|
1 |
S1 |
p. S28-S33
6 p.
|
article
|
| 7 |
Introduction
|
Piccart, Martine J.
|
|
2000
|
1 |
S1 |
p. S7-S8
2 p.
|
article
|
| 8 |
Overview of Epirubicin-Based Adjuvant Therapy in Breast Cancer
|
Untch, Michael
|
|
2000
|
1 |
S1 |
p. S41-S45
5 p.
|
article
|
| 9 |
Promising Results with Exemestane in the First-Line Treatment of Metastatic Breast Cancer: A Randomized Phase II EORTC Trial with a Tamoxifen Control
|
Paridaens, Robert
|
|
2000
|
1 |
S1 |
p. S19-S21
3 p.
|
article
|
| 10 |
Rationale and Design of a Phase III Trial of Adjuvant Sequential Epirubicin/Cyclophosphamide and Taxane Versus Concurrent Epirubicin/Taxane in Operable Node-Positive Breast Cancer
|
Perez, Edith A.
|
|
2000
|
1 |
S1 |
p. S52-S56
5 p.
|
article
|
| 11 |
Rationale and Use of Epirubicin-Based Therapy in the Adjuvant Setting
|
Mouridsen, Henning T.
|
|
2000
|
1 |
S1 |
p. S34-S40
7 p.
|
article
|
| 12 |
Role of Epirubicin in Advanced Breast Cancer
|
Conte, Pier Franco
|
|
2000
|
1 |
S1 |
p. S46-S51
6 p.
|
article
|
| 13 |
Selection Criteria for Epirubicin-Based Adjuvant Chemotherapy in Node-Negative Breast Cancer
|
Jänicke, Fritz
|
|
2000
|
1 |
S1 |
p. S57-S61
5 p.
|
article
|
| 14 |
The Role of Vascular Endothelial Growth Factor (VEGF) in Tumor Angiogenesis and Early Clinical Development of VEGFReceptor Kinase Inhibitors
|
Verheul, Henk M.W.
|
|
2000
|
1 |
S1 |
p. S80-S84
5 p.
|
article
|
| 15 |
Treating Breast Precancer
|
O'Shaughnessy, Joyce A.
|
|
2000
|
1 |
S1 |
p. S74-S79
6 p.
|
article
|
Journal description